Metabolomics Creative Proteomics

Blood & Plasma & Serum Metabolomics Service

Drive confident discoveries with matrix-optimized metabolomics for blood, plasma, and serum. Creative Proteomics provides untargeted and targeted LC-MS/GC-MS data you can trust—standardized methods, transparent QC, and clear biological context, so you move from spectra to decisions fast.

  • Coverage: >1,000 features in untargeted runs; amino acids → lipids
  • Quant: nM–pM LLOQ; pooled-QC CV ≤15–20%
  • Sample-friendly: 50–200 μL per channel
  • Scalable: pilot studies to large cohorts
  • Comparable: plasma/serum standards enable cross-study benchmarking
  • Actionable: pathway enrichment & publication-ready figures
CONTACT EXPERT

Curious about Metabolomics?

Download Our Brochure to Learn More!

  • Service Details
  • FAQ
  • Publications
  • Submit Your Inquiry

What is Blood / Plasma / Serum Metabolomics and Why Choose These Matrices?

Blood, plasma, and serum are among the most informative and widely used matrices in metabolomics. They integrate metabolites from multiple organs and the microbiome, providing a systemic snapshot of physiological and metabolic states. Compared with tissues, blood sampling is less invasive, more repeatable, and suitable for large-scale or longitudinal studies.

With high-resolution mass spectrometry, these matrices enable:

  • Comprehensive profiling across amino acids, lipids, bile acids, and more
  • Sensitive detection of biological responses to compounds, nutrition, or environmental exposures
  • Robust integration with other omics for systems-level insights

Plasma (anticoagulated supernatant) and serum (post-clot fraction) each have unique characteristics, but both offer well-established, standardized protocols that support consistent, comparable, and decision-ready metabolomics data.

How to Choose Between Blood / Plasma / Serum?

Matrix What it is When to Choose Key Advantages Things to Keep in Mind Best Fit (RUO)
WholeBlood Contains both the cellular fraction and plasma. When you need insights from both intracellular and extracellular metabolites, such as redox balance or glycolysis. Broad systemic snapshot including cell-derived metabolites. Very sensitive to handling; processing must be strict and consistent. Untargeted: Good
Targeted: Good
Plasma (EDTA / Heparin) The cell-free fraction obtained after anticoagulation and centrifugation. When you want a versatile, standardized, and widely benchmarked matrix. Minimizes clotting artifacts; highly reproducible; ideal for discovery and quantitation. Anticoagulant choice matters (EDTA for polar metabolites; heparin for lipidomics). Untargeted: Excellent
Targeted: Excellent
Serum The liquid fraction collected after clotting and centrifugation. When you rely on biobanked or legacy samples, or need comparability with published serum data. Broad availability in existing collections; strong alignment with literature. Clotting alters certain peptides/lipids; ensure clotting conditions are standardized. Untargeted: Good–Excellent
Targeted: Good–Excellent

Comprehensive Blood, Plasma & Serum Metabolomics Solutions

Untargeted Metabolomics

  • Broad-spectrum metabolite profiling using LC–MS (HILIC/RP, ESI±) and GC–MS (EI).
  • Captures a wide range of small molecules, from amino acids and organic acids to sugars and lipids.
  • Ideal for exploratory studies, biomarker discovery, and hypothesis generation.

Targeted Metabolomics

Stable Isotope Tracing (Optional)

Bioinformatics & Statistical Support

  • Advanced data processing, normalization, and metabolite annotation.
  • Comprehensive statistical and pathway analyses to contextualize results.
  • Designed to integrate seamlessly with multi-omics datasets.

Why Choose Our Metabolomics Analysis: Key Advantages

  • Broad Metabolite Coverage

Untargeted LC–MS and GC–MS can detect >1,000 metabolites/features, spanning amino acids, organic acids, nucleotides, sugars, bile acids, and lipids.

  • High Sensitivity & Reproducibility

Targeted LC–MS/MS achieves nM–pM detection limits with typical CV ≤15–20%, ensuring robust quantitation.

  • Efficient Sample Use

Workflows require only 50–200 μL per channel, enabling analysis of valuable or limited-volume samples.

  • Scalable Throughput

Automated pipelines process hundreds of samples per week, supporting both pilot and large-cohort studies.

  • Pathway-Level Insights

Profiles map to 50+ metabolic pathways, enabling system-level interpretation and integration with other omics.

  • Cross-Study Comparability

Plasma and serum are the most common matrices in metabolomics publications, ensuring alignment with public datasets and literature.

Analytical Platforms for Blood, Plasma and Serum Metabolomics Services

High-Resolution LC–MS (Untargeted)

  • Instruments: Thermo Orbitrap Exploris 240/480, Q Exactive
  • Parameters: Resolution 60,000–120,000 FWHM, accuracy ≤5 ppm, scan range m/z 50–1,500, polarity switching
  • Use: Global profiling of amino acids, organic acids, nucleotides, sugars, bile acids, and lipids

GC–MS (Volatile & Derivatized Metabolites)

  • Instruments: Agilent 7890B GC + 5977B MSD (EI, 70 eV)
  • Parameters: Scan m/z 50–600, retention index calibration
  • Use: Organic acids, sugars, amino acids (derivatized), SCFAs, volatiles

Triple Quadrupole LC–MS/MS (Targeted Panels)

  • Instruments: Sciex 6500+ QTRAP, Agilent 6495C
  • Parameters: MRM/SRM, quantitation across 3–4 orders of magnitude, LLOQ in nM–pM range
  • Use: Absolute quantitation of amino acids, bile acids, acylcarnitines, TCA intermediates, biogenic amines, vitamins, lipids

Stable Isotope Tracing (Optional)

  • Instruments: Orbitrap / QTOF platforms
  • Parameters: Full-scan + MS/MS, isotopologue correction
  • Use: Pathway routing and metabolic flux studies
Thermo Orbitrap Exploris 240

Orbitrap Exploris 240 (Figure from Thermo)

7890B Gas Chromatograph + 5977 Single Quadrupole

Agilent 7890B-5977B (Figure from Agilent)

SCIEX Triple Quad 6500+

SCIEX Triple Quad™ 6500+ (Figure from Sciex)

Agilent 6495C Triple quadrupole

Agilent 6495C Triple quadrupole (Figure from Agilent)

How Our Blood, Plasma & Serum Metabolomics Assay Works — Step-by-Step Process

1

Consultation & Study Design

Understand research objectives (exploratory vs. targeted). Advise on matrix selection (blood, plasma, or serum) and analytical strategy. Provide guidelines for sample collection, anticoagulant choice, and storage.

2

Sample Submission & Quality Check

Receive and register samples under strict cold-chain conditions. Assess sample integrity (e.g., volume, hemolysis, lipemia). Document metadata (collection time, fasting status, storage history).

3

Sample Preparation & Extraction

Apply matrix-specific extraction protocols (polar vs. non-polar). Spike with isotopically labeled internal standards. Process blanks and pooled QCs alongside study samples.

4

Instrumental Analysis

  • Untargeted: High-resolution LC–MS and GC–MS for broad coverage.
  • Targeted: Triple quadrupole LC–MS/MS (MRM/SRM) for absolute quantitation.
  • Optional: Stable isotope tracing for flux studies.
  • Randomized run order and repeated QC injections to monitor system stability.
5

Data Processing & Identification

Convert raw files into open formats (e.g., mzML). Perform peak picking, alignment, normalization, and drift correction. Annotate metabolites with reference standards, spectral libraries, and MSI confidence levels.

6

Statistical & Pathway Analysis

Apply univariate and multivariate statistics (PCA, PLS-DA, volcano plots). Conduct pathway enrichment using KEGG, Reactome, and LIPID MAPS. Highlight significant metabolites and biological themes relevant to the study.

Blood, Plasma & Serum Metabolomics Analysis Workflow

Sample Requirements for Metabolomics Service

Matrix Untargeted LC–MS* Targeted LC–MS/MS* GC–MS* Key Notes
Whole Blood 100–200 μL 50–100 μL 50–100 μL Handling-sensitive; avoid hemolysis; chill immediately and freeze promptly.
Plasma (EDTA) 100–200 μL 50–100 μL 50–100 μL Preferred for polar/untargeted work; keep cold after draw; minimize freeze–thaw.
Plasma (Heparin) 100–200 μL 50–100 μL 50–100 μL Common for lipid-focused assays; keep the anticoagulant consistent across the cohort.
Serum 100–200 μL 50–100 μL 50–100 μL Standardize clot time/temperature; centrifuge promptly; document pre-analytical variables.

*Volumes are per single analytical channel. For multi-channel designs (e.g., untargeted + targeted + GC–MS), sum the volumes and add 10–20% reserve for repeats/QC.

General Rules for Sample Handling

  • Aliquot: 50–100 μL per cryovial; prepare enough to avoid repeat freeze–thaw.
  • Storage: Low-bind screw-cap tubes, -80°C; ship on dry ice.
  • Metadata: Record anticoagulant type, hemolysis/lipemia, diet/fasting, clot time (serum), storage history.
  • Consistency: Use one matrix + one anticoagulant across the study.
  • Micro-volume: Low-volume workflows available on request.

Deliverables: What You Receive from Our Blood / Plasma / Serum Metabolomics Analysis

  • Raw data files: instrument vendor formats (e.g., .raw, .wiff) and converted open formats (.mzML*).
  • Processed datasets: feature/peak tables with retention time, m/z, intensities, and metabolite annotations (with MSI confidence levels).
  • Quantitative results: absolute concentrations for targeted panels; normalized relative abundances for untargeted assays.
  • QC reports: summaries of internal standards, pooled QCs, blanks, and key acceptance metrics (mass accuracy, %CV, retention time stability).
  • Statistical outputs: PCA, PLS-DA, volcano plots, clustering heatmaps, and pathway enrichment results (KEGG, Reactome, LIPID MAPS).
LC–MS total ion chromatogram from 0–20 minutes showing several resolved peaks and a stable baseline.

LC–MS TIC (0–20 min); multiple resolved peaks with a stable baseline.

GC–MS total ion chromatogram from 0–30 minutes with sharp peaks and low-noise baseline, representative of metabolomics.

GC–MS TIC (0–30 min); sharp Gaussian peaks with low-noise baseline.

Metabolomics PCA score plot showing separation between groups on PC1/PC2 and tight clustering of QC samples.

PCA score plot; clear group separation along PC1/PC2 and tight QC clustering.

Volcano plot with log2 fold change versus −log10 p-value highlighting significant up- and down-regulated metabolites.

Volcano plot of differential metabolites; significant up/down features highlighted and labeled.

What is blood, plasma, and serum metabolomics commonly used for?

It is widely applied to biomarker discovery, nutrition and toxicology research, pharmacometabolomics, microbiome–host interaction studies, and systems biology, where systemic and quantitative insights into metabolism are needed.

How do I decide between plasma and serum for my study?

Plasma is generally preferred when consistency and reduced clotting artifacts are critical, while serum is often used for legacy or biobank projects where comparability with historical datasets matters. The choice should be consistent across your cohort to reduce pre-analytical bias.

What types of metabolites can be detected in blood, plasma, or serum?

Depending on the method, detection covers amino acids, organic acids, nucleotides, sugars, fatty acids, bile acids, acylcarnitines, biogenic amines, vitamins, and hundreds of lipid species, enabling broad coverage of central and peripheral metabolic pathways.

Can metabolomics be performed with limited sample volume?

Yes. Modern LC–MS and GC–MS workflows require only microliter quantities, making them suitable for valuable or scarce samples, with low-volume methods available upon request.

How reliable are the results from blood, plasma, and serum metabolomics?

Results are supported by stable isotope internal standards, pooled quality controls, and library-based metabolite identification aligned with MSI levels, ensuring reproducibility and confidence in the data.

Is it possible to integrate blood, plasma, or serum metabolomics with other omics?

Yes. These matrices are commonly integrated with genomics, transcriptomics, proteomics, and microbiome data, providing a complementary metabolic layer for systems-level interpretation.

Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy

van Hummel, A., Taleski, G., Sontag, J. M., Feiten, A. F., Ke, Y. D., Ittner, L. M., & Sontag, E.

Journal: Neuropathology and Applied Neurobiology

Year: 2023

Exogenous lipase administration alters gut microbiota composition and ameliorates Alzheimer's disease-like pathology in APP/PS1 mice

Menden, A., Hall, D., Hahn-Townsend, C., Broedlow, C. A., Joshi, U., Pearson, A., ... & Ait-Ghezala, G.

Journal: Scientific Reports

Year: 2022

Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans

Ryan O. Walters, et al.

Journal: Cell Reports

Year: 2018

Characterization of Dnajc12 knockout mice, a model of hypodopaminergia

Deng, I. B., Follet, J., Fox, J. D., & Farrer, M. J.

Journal: bioRxiv

Year: 2024

Quantification of choline in serum and plasma using a clinical nuclear magnetic resonance analyzer

Garcia, E., Shalaurova, I., Matyus, S. P., Wolak-Dinsmore, J., Oskardmay, D. N., & Connelly, M. A.

Journal: Clinica Chimica Acta

Year: 2022

Function and regulation of a steroidogenic CYP450 enzyme in the mitochondrion of Toxoplasma gondii

Asady, B., Sampels, V., Romano, J. D., Levitskaya, J., Lige, B., Khare, P., ... & Coppens, I.

Journal: PLoS Pathogens

Year: 2023

For Research Use Only. Not for use in diagnostic procedures.
Submit Your Inquiry
return-top